NCI vs GOOS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

NCI

41.1
AI Score
VS
NCI Wins

GOOS

38.7
AI Score

Investment Advisor Scores

NCI

41score
Recommendation
HOLD

GOOS

39score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric NCI GOOS Winner
Forward P/E 0 9.1241 Tie
PEG Ratio 1.13 3.02 NCI
Revenue Growth -50.8% 10.3% GOOS
Earnings Growth 34.0% 3.0% NCI
Tradestie Score 41.1/100 38.7/100 NCI
Profit Margin 0.2% 3.7% GOOS
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL NCI

Relative Price Performance (Last 90 Days)

NCI 1M: +5.8% · 3M: +18.2% GOOS 1M: -8.2% · 3M: -22.1%

Current Technical Phase

NCI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.8% over 20 days), RSI 53

RSI (14): 53.0 · Price: $12.97

GOOS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.3%), weak momentum, RSI 39

RSI (14): 39.4 · Price: $7.93

Fundamentals Snapshot

Metric NCI GOOS
Market Cap
Forward P/E 0.0 10.8
Trailing P/E 158.6 17.7
Revenue (TTM)
Revenue Growth -0.5% 0.1%
Gross Margin 0.4% 0.7%
Operating Margin 0.0% -0.9%
EPS 0.08 0.43
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, NCI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.